Bacterial Pathogens and Diseases I (Exotoxins) Flashcards

1
Q

Define pathogen.

A

A microorganism capable of causing disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define pathogenicity.

A

The ability of an infectious agent to cause disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define virulence.

A

The quantitative ability of an agent to cause disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define toxigenicity.

A

The ability of a microorganism to produce a toxin that contributes to the development of disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List some virulence mechanisms.

A
  • adherence factors
  • biofilms
  • invasion of host cells and tissues
  • toxins (endotoxins and exotoxins)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are exotoxins?

A
  • a heterogeneous group of proteins produced and secreted by living bacterial cells
  • produced by both gram negative and gram positive bacteria.
  • cause disease symptoms in host during disease.
  • act via a variety of diverse mechanisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What selective advantages do exotoxins give to the bacteria?

A

They may help in transmission of disease; however in severe disease host may be a literal and evolutionary dead end.

However, with many toxins the disease causing activity may be not be the primary function.

Other activities:

  • evade immune response
  • enable biofilm formation
  • enable attachment to host cells.
  • escape from phagosomes

All these activities allow for colonisation, niche establishment and carriage - the bacteria has evolutionary
advantage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Looking at a specific disease, in the case of Staphylococcus aureus, what toxins does it produce and what are their functions?

A

Haemolytic toxins:

  • cause cells to lyse by forming pores
  • are an important cause of features of S. aureus disease.
  • examples include: α, β, δ, toxins ,Panton Valentine Leukocidin (PVL), LukAB, LukED, LukMF

Phenol soluble modulins (PSM):
- aggregate the lipid bilayer of host cells - lysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In the case of Staphylococcus aureus, why does it have these toxins?

A

The α toxins inhibit the attachement of the lysosome to the phagosome, meaning that the S. aureus can survive longer.

PSMs kill off other bacteria, so there is less competition over resources.
They also allow the S aureus to slide acorss surfaces and move, as it is not too motile on its own.

In terms of the infection itself, the α toxin helps in its initial attachment, the β toxin aids in the accumulation of the bacteria, and the PSMs help in the detachment when needed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Expand on the genetics of exotoxins.

A

Exotoxins can be encoded by chromosomal genes. Examples:

  • Shiga toxin in Shigella dysenteriae
  • TcdA & TcdB in C. difficile

Many toxins are coded by extrachromosomal genes.

  • plasmids – Bacillus anthracis toxin, tetanus toxin
  • lysogenic bacteriophage – e.g. streptococcal pyrogenic exotoxins in Scarlet Fever, Diphtheria toxin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the classification of exotoxins.

A

As they are a very diverse group of proteins, there are many ways to classify.
Classification can be by the toxins activity .

  • Membrane Acting Toxins – Type I
  • Membrane Damaging Toxins – Type II
  • Intracellular Toxins – Type III

This classification has its problems:

  • many toxins may have more than one type activity.
  • as the mechanisms get better understood, this classification tends to break down.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe membrane acting toxins – Type I.

A

ACT: act from without
the cell.

INTERFERE: interfere with host cell signaling by inappropriate activation of host cell receptors.

TARGET: Target receptors
include
- Guanylyl cyclase → ↑ intracellular cGMP
- Adenyl cyclase → ↑ intracellular cAMP
- Rho proteins
- Ras proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe membrane damaging toxins – Type II.

A

They cause damage to the host cell membrane.

  1. They insert channels into host cell membrane:
    - β sheet toxins e.g. S.aureus α – toxin, δ toxin, PVL
    - α helix toxins – e.g. diphtheria toxin
  2. Enzymatical damage e.g. S. aureus β- haemolysin

They can either be receptor mediated or receptor independant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe intracellular toxins – Type III.

A

They are active within the cell – they must gain access to the cell.

They usually have 2 components – AB toxins:

  • receptor binding and translocation function – B
  • toxigenic (enzymatic) – A

They may be single or multiple B units e.g. Cholera toxin AB(5).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In intracellular toxins, the enzymatic component A has a variety of activities.

List some of them.

A
  • ADP – ribosyl transferases - e.g. Exotoxin A of Pseudomonas aeruginosa, pertussis toxin.
  • Glucosyltransferases – e.g. TcdA and TcdB of Clostridium difficile
  • Deamidate – e.g. dermonecrotic toxin of Bordetella pertussis.
  • Protease – e.g. Clostridial neurotoxins: botulism & tetanus
  • Adenylcyclase - e.g. EF toxin of Bacillus anthracis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Expand on superantigens and inflammatory cytokines.

A

Exotoxins are able to induce inflammatory cytokine release, such as: IL-1, IL-1β, TNF, IL-6,δ interferon, IL-18

MECHANISMS:
- Superantigen – non specific bridging of the MHC Class II and T- cell receptor leading to cytokine production. E.g. Staphylococcal Exfoliative Toxin A, Toxic Shock Syndrome Toxin 1 (TSST1)

  • Via activation of the different inflammasome leading to release IL-1β and IL-18 e.g. S. aureus toxin A, PVL.
17
Q

Expand on toxoids, vaccine and antibodies.

A

Toxins can be inactivated using formaldehyde or glutaraldehyde, at which they become toxoids.

Toxoids are inactive proteins but still highly immunogenic – they form the basis for vaccines:

  • Tetanus Vaccine
  • Diphtheria
  • Pertussis (acellular).*

Treatment of toxin mediated disease can be affected by administering preformed antibodies to the toxin:

  • Diphtheria antitoxin – horse antibodies.
  • Tetanus – pooled human immunoglobulin. Specific or normal.
  • Botulism – horse antibodies

Monoclonal antibodies are still very much experimental and not used routinely at the moment.

18
Q

Describe the microbiology of Clostridium difficile.

A
  • Gram-positive bacillus.
  • Anaerobic.
  • Spore-forming.
  • Toxin-producing.
  • Can be carried asymptomatically in the gut.
  • produces 3 toxins.
19
Q

Describe the epidemiology (incidence, etc.) of Clostridium difficile.

A
  • it’s a common hospital acquired infection
    worldwide
  • it’s spread by ingestion of spores – remains dormant in environment
  • it’s a coloniser of the human gut in up to 5% in
    adults

Risk Factors –

  • antibiotic use
  • age
  • antacids
  • prolonged hospital stay
20
Q

How do antibiotics affect C. difficile?

A

Antibiotics are thought to act by disrupting the microbial ecosystem within the gut.
Antibiotics provide a competitive advantage to spore forming anaerobes (like C difficile) over non spore forming anaerobes.

This allows C. difficile colonisation and growth.

All antibiotics have potential for causing disease.

Some antibiotics are worse than others:

  • 2nd and 3rd generation cephalosporins
  • Quinolones
  • Clindamycin?

Others are less likely to cause damage:

  • Aminoglycosides
  • Trimethoprim
  • Vancomycin
21
Q

Describe the toxins in C. difficile.

A

Cytotoxin A - TcdA coded by tcdA gene

Cytotoxin B – TcdB coded by tcdB gene

Binary toxin – C. diff transferase (CDT) – minor role in disease

Tcd A and Tcd B – Type III AB toxins.
The A component of toxins are glycosylating enzymes.

22
Q

Describe the mechanism of action of the TcdA/TcdB toxin.

A
  1. Toxins bind to specific host cell receptors.
  2. The toxins are internalised by the cell.
  3. The endosome in which the toxin is in is acidified.
  4. There is pore formation on the endosome.
  5. GTD is released from the endosome to the host cell cytoplasm.
  6. Rho GTPases are inactivated by glycosylation.
  7. There are downstream effects within the host cell.
23
Q

What are the effects of the inactivated Rho GTPases in the cell?

A

CYTOPATHIC EFFECTS:

  • cytoskeleton breakdown
  • loss of cell-cell contacts
  • increased epithelial permeability

CYTOTOXIC EFFECTS:

  • activation of the inflammasome
  • increase in ROS levels
  • induction of programmed cell death
24
Q

What are some symptoms of the C difficile disease?

A

It can range from:

  • asymptomatic
  • watery diarrhoea
  • dysentry
  • pseudomembranous colitis
  • toxic megacolon and peritonitis
25
Q

How would you diagnose C. difficile?

A

There are clinical signs and symptoms
There is a raised white cell count in blood.

There is detection of organisms and toxins in stool
It’s a 2 phase test:
- glutamate dehydrogenase – detects if C. difficile organism present.
- toxin enzyme linked immunosorbent assay (ELISA) for TcdA and TcdB toxins.

There is detection of tcdA and tcdb genes – PCR.
Finally, we can perform a colonoscopy – pseudomembranous colitis.

26
Q

How would you treat C. difficile?

A

The treatment is dependent on severity and presence of surgical complications.

Ideally, it is the removal of the offending antibiotic – this is not always possible.

You could use antibiotics: fidaxomicin or metronidazole or vancomycin.

You can perform surgery – partial or total colectomy.
If it is recurrent , you can look towards a faecal transplant.

27
Q

What is the VTEC/STEC disease?

A

VTEC, or Shiga-toxin (Stx) producing E. coli (STEC) can cause disease mild to life threatening disease.

Stx is carried by some E. coli – most commonly O157:H7

It’s identified usually by growth on sorbitol MacConkey agar (SMac)
– it does not ferment sorbitol and hence is clear.
Other less common types are not identified using SMac.

28
Q

What is the epidemiology of VTEC/STEC?

A

E. coli O157:H7 naturally colonizes the gastrointestinal tracts of cattle who are generally asymptomatic.

TRANSMISSION:

  • predominantly via consumption of contaminated food and water
  • person to person, particularly in child day-care facilities, and from
  • animal to person. E.g. in petting zoos, dairy farms, or camp grounds.

It has a very low infectious dose.

29
Q

What is the pathogenesis of the toxins of VTEC?

A

It’s called Shiga like toxin (SLT) = shigatoxin (Stx) = verocytotoxin (VTEC).

There are many types: Stx, Stx1, Stx1a, 1c, 1d Stx2a, 2c, 2d – they just have variations in the amino acid sequence.

The gene is carried on lysogenic viruses.

There’s also a Type III exotoxin – AB5.
it has an enzymatic component A = N-Glycosidase. It is bound to 5 B subunits.

30
Q

Describe the mechanism of the shigatoxin.

A

it binds to receptor globotriaosylceramide Gb3 or globotetraosylceramide (Gb4) on host cell membrane.

The bound toxin is internalised by receptor-mediated endocytosis.

It’s carried by retrograde trafficking via the Golgi
apparatus to the endoplasmic reticulum.

The A subunit is cleaved off by membrane bound proteases.

Once in the cytoplasm, A1 and A2 disassociate.
A1 binds to 28S RNA subunit – which blocks protein synthesis.

31
Q

Describe the pathogenesis of VTEC.

A

STEC closely adheres to the epithelial cells of the gut mucosa.
The route by which Stx is transported from the intestine to the kidney and other tissues is debated; it could happen possibly by polymorphonuclear neutrophils (PMNs).

They bind to glomerular endothelial cells of kidney, cardiovascular and central nervous system.
There are very high levels of Gb3 in the kidney so the kidneys most affected.

It is thought that Stx favours inflammation resulting in microvascular thrombosis and inhibition of fibrinolysis.

32
Q

Describe the symptoms and disease of VTEC.

A

It can be severe and life threatening. Children < 5 years are at the greatest risk.

you can get abdominal cramps, watery or bloody diarrhoea – these may or may not be present.

Youcould also get haemolytic uraemic syndrome:

  • anaemia
  • renal Failure
  • thrombocytopaenia

Less common are neurological symptoms, such as:

  • lethargy
  • severe headache
  • convulsions
  • encephalopathy
33
Q

How would we diagnose and treat VTEC?

A

DIAGNOSIS:

  • clinical signs and symptoms
  • haematological and biochemical evidence
  • stool culture – Growth on SMac
  • PCR for Stx genes

TREATMENT:

  • supportive including renal dialysis and blood product transfusion
  • antibiotics have little to no role